Across TCGA pan-cancer cohorts, USP9YP25 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated USP9YP25 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher USP9YP25 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated USP9YP25 expression acts as an unfavorable survival marker.

STAD are the cancer types where USP9YP25 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	III,IV	0.183	0.632	.017	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: USP9YP25 tumor-vs-normal RNA expression · all USP9YP25 data types